77 related articles for article (PubMed ID: 35461390)
21. Sentinel lymph node biopsy in endometrial cancer: state of the art.
Della Corte L; Giampaolino P; Mercorio A; Riemma G; Schiattarella A; De Franciscis P; Bifulco G
Transl Cancer Res; 2020 Dec; 9(12):7725-7733. PubMed ID: 35117375
[TBL] [Abstract][Full Text] [Related]
22. The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillance.
Grandi G; Fiocchi F; Cortesi L; Toss A; Boselli F; Sammarini M; Sighinolfi G; Facchinetti F
Menopause; 2021 Nov; 29(1):63-72. PubMed ID: 34726192
[TBL] [Abstract][Full Text] [Related]
23. Poly (ADP-ribose) polymerase (PARP) as target for the treatment of epithelial ovarian cancer: what to know.
Della Corte L; Foreste V; Di Filippo C; Giampaolino P; Bifulco G
Expert Opin Investig Drugs; 2021 May; 30(5):543-554. PubMed ID: 33724122
[TBL] [Abstract][Full Text] [Related]
24. Comparison of three biopsy forceps for hysteroscopic endometrial biopsy in postmenopausal patients (HYGREB-1): A multicenter, single-blind randomized clinical trial.
Vitale SG; Laganà AS; Caruso S; Garzon S; Vecchio GM; La Rosa VL; Casarin J; Ghezzi F
Int J Gynaecol Obstet; 2021 Dec; 155(3):425-432. PubMed ID: 33686708
[TBL] [Abstract][Full Text] [Related]
25. Endometrial cancer: A systematic review of HE4, REM and REM-B.
Degez M; Caillon H; Chauviré-Drouard A; Leroy M; Lair D; Winer N; Thubert T; Dochez V
Clin Chim Acta; 2021 Apr; 515():27-36. PubMed ID: 33388311
[TBL] [Abstract][Full Text] [Related]
26. The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study.
Funston G; Hamilton W; Abel G; Crosbie EJ; Rous B; Walter FM
PLoS Med; 2020 Oct; 17(10):e1003295. PubMed ID: 33112854
[TBL] [Abstract][Full Text] [Related]
27. Role of biomarkers for early detection of ovarian cancer recurrence.
Giampaolino P; Foreste V; Della Corte L; Di Filippo C; Iorio G; Bifulco G
Gland Surg; 2020 Aug; 9(4):1102-1111. PubMed ID: 32953625
[TBL] [Abstract][Full Text] [Related]
28. Romo1 Inhibition Induces TRAIL-Mediated Apoptosis in Colorectal Cancer.
Jo MJ; Kim BG; Park SH; Kim HJ; Jeong S; Kim BR; Kim JL; Na YJ; Jeong YA; Yun HK; Kim DY; Han J; Heo JY; Yoo YD; Lee DH; Oh SC
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825500
[TBL] [Abstract][Full Text] [Related]
29. The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: a prospective cohort, other biomarker controlled, study.
Grandi G; Del Savio MC; Sammarini M; Cortesi L; Toss A; Piombino C; Facchinetti F
Eur J Cancer Prev; 2020 Jul; 29(4):350-356. PubMed ID: 32516171
[TBL] [Abstract][Full Text] [Related]
30. Hysteroscopic treatment of submucosal fibroids in perimenopausal women: when, why, and how?
Vitale SG; Riemma G; Ciebiera M; Cianci S
Climacteric; 2020 Aug; 23(4):355-359. PubMed ID: 32410475
[TBL] [Abstract][Full Text] [Related]
31. The generally low sensitivity of CA 125 for FIGO stage I ovarian cancer diagnosis increases for endometrioid histotype.
Grandi G; Perrone AM; Toss A; Vitagliano A; Friso S; Facchinetti F; Cortesi L; Cascinu S; De Iaco P
Minerva Med; 2020 Apr; 111(2):133-140. PubMed ID: 32338842
[TBL] [Abstract][Full Text] [Related]
32. Ovarian Cancer Biomarkers: Moving Forward in Early Detection.
Bonifácio VDB
Adv Exp Med Biol; 2020; 1219():355-363. PubMed ID: 32130708
[TBL] [Abstract][Full Text] [Related]
33. Innovations in hysteroscopic surgery: expanding the meaning of "in-office".
Vitale SG; Haimovich S; Riemma G; Ludwin A; Zizolfi B; De Angelis MC; Carugno J
Minim Invasive Ther Allied Technol; 2021 Jun; 30(3):125-132. PubMed ID: 31971476
[TBL] [Abstract][Full Text] [Related]
34. The Biopsy Snake Grasper Sec. VITALE: A New Tool for Office Hysteroscopy.
Vitale SG
J Minim Invasive Gynecol; 2020; 27(6):1414-1416. PubMed ID: 31884079
[TBL] [Abstract][Full Text] [Related]
35. Cancer and Cancer Stem Cells: New Molecular Perspectives.
Gurel C; Inetas G; Hortu I; Tunc E; Kuscu GC; Dindaroglu FC; Sahin O; Buhur A; Oktem G
Crit Rev Oncog; 2019; 24(1):99-104. PubMed ID: 31679224
[TBL] [Abstract][Full Text] [Related]
36. Reactive Oxygen Species Modulator 1 (ROMO1), a New Potential Target for Cancer Diagnosis and Treatment.
Amini MA; Talebi SS; Karimi J
Chonnam Med J; 2019 Sep; 55(3):136-143. PubMed ID: 31598470
[TBL] [Abstract][Full Text] [Related]
37. Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
Grandi G; Perrone AM; Chiossi G; Friso S; Toss A; Sammarini M; Facchinetti F; Botticelli L; Palma F; De Iaco P
Gynecol Oncol; 2019 Jul; 154(1):163-168. PubMed ID: 31104904
[TBL] [Abstract][Full Text] [Related]
38. Oxidative Stress and Cancer.
Klaunig JE
Curr Pharm Des; 2018; 24(40):4771-4778. PubMed ID: 30767733
[TBL] [Abstract][Full Text] [Related]
39. Cancer biomarker discovery and translation: proteomics and beyond.
Hristova VA; Chan DW
Expert Rev Proteomics; 2019 Feb; 16(2):93-103. PubMed ID: 30556752
[TBL] [Abstract][Full Text] [Related]
40. Cancer of the ovary, fallopian tube, and peritoneum.
Berek JS; Kehoe ST; Kumar L; Friedlander M
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():59-78. PubMed ID: 30306591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
